Medindia LOGIN REGISTER
Medindia
Advertisement

Phio Pharmaceuticals Reports First Quarter 2019 Financial Results and Corporate Highlights

Wednesday, May 15, 2019 General News
Advertisement
- Expansion of Industry Partners With Glycostem Therapeutics BV Collaboration

PHIO PHARMACEUTICALS CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts in thousands)

(Unaudited)

March 31,

December 31,

2019

2018

ASSETS

Current assets:

Cash

$            12,746

$            14,879

Restricted cash

50

50

Prepaid expenses and other current assets

117

221

Total current assets

12,913

15,150

Right of use asset

592



Property and equipment, net

155

172

Other assets

18



Total assets

$            13,678

$            15,322

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable

$                 721

$                 550

Accrued expenses

703

1,194

Lease liability

92



Total current liabilities

1,516

1,744

Lease liability, net of current portion

500



Total liabilities

2,016

1,744

Total stockholders' equity

11,662

13,578

Total liabilities and stockholders' equity

$            13,678

$            15,322

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close